AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks 14 day Free Trial

IMPEDIMED LIMITED (IPD)


AI Coverate Rating: Moderate

ASX AI Signals has generated 2 signal(s) for IPD during the last 90 days, indicating Moderate trading activity
Last signal: BUY on 26/05/2026


Current Price:   $0.007
52 Week High: $0.057
52 Week Low:  $0.006
Trading at 12.28% of its 52-week high


Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial

Business Overview

Impedimed Limited (ASX: IPD) develops and markets bioimpedance measurement devices used for the detection and monitoring of lymphatic system disorders. Their technology helps healthcare professionals manage conditions such as lymphedema by providing accurate, non-invasive assessments. The company serves medical markets worldwide with a focus on improving patient outcomes.

Latest  IMPEDIMED LIMITED(IPD)   News

08 Apr 2026, 06:29 AM

ImpediMed Appoints Erik Anderson as Chief Executive Officer

Former Hologic executive to lead next phase of growth and commercial execution for medical technology leader CARLSBAD, Calif., April 7, 2026 /PRNewswire/ -- ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composi

Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial